{"2501.15733": {"publish_time": "2025-01-27", "title": "Leveraging Video Vision Transformer for Alzheimer's Disease Diagnosis from 3D Brain MRI", "paper_summary": "Alzheimer's disease (AD) is a neurodegenerative disorder affecting millions\nworldwide, necessitating early and accurate diagnosis for optimal patient\nmanagement. In recent years, advancements in deep learning have shown\nremarkable potential in medical image analysis. Methods In this study, we\npresent \"ViTranZheimer,\" an AD diagnosis approach which leverages video vision\ntransformers to analyze 3D brain MRI data. By treating the 3D MRI volumes as\nvideos, we exploit the temporal dependencies between slices to capture\nintricate structural relationships. The video vision transformer's\nself-attention mechanisms enable the model to learn long-range dependencies and\nidentify subtle patterns that may indicate AD progression. Our proposed deep\nlearning framework seeks to enhance the accuracy and sensitivity of AD\ndiagnosis, empowering clinicians with a tool for early detection and\nintervention. We validate the performance of the video vision transformer using\nthe ADNI dataset and conduct comparative analyses with other relevant models.\nResults The proposed ViTranZheimer model is compared with two hybrid models,\nCNN-BiLSTM and ViT-BiLSTM. CNN-BiLSTM is the combination of a convolutional\nneural network (CNN) and a bidirectional long-short-term memory network\n(BiLSTM), while ViT-BiLSTM is the combination of a vision transformer (ViT)\nwith BiLSTM. The accuracy levels achieved in the ViTranZheimer, CNN-BiLSTM, and\nViT-BiLSTM models are 98.6%, 96.479%, and 97.465%, respectively. ViTranZheimer\ndemonstrated the highest accuracy at 98.6%, outperforming other models in this\nevaluation metric, indicating its superior performance in this specific\nevaluation metric. Conclusion This research advances the understanding of\napplying deep learning techniques in neuroimaging and Alzheimer's disease\nresearch, paving the way for earlier and less invasive clinical diagnosis.", "paper_summary_zh": "\u963f\u8332\u6d77\u9ed8\u75c7 (AD) \u662f\u4e00\u7a2e\u795e\u7d93\u9000\u5316\u6027\u75be\u75c5\uff0c\u5f71\u97ff\u8457\u5168\u7403\u6578\u767e\u842c\u4eba\uff0c\u56e0\u6b64\u9700\u8981\u65e9\u671f\u6e96\u78ba\u8a3a\u65b7\u4ee5\u9032\u884c\u6700\u4f73\u60a3\u8005\u7ba1\u7406\u3002\u8fd1\u5e74\u4f86\uff0c\u6df1\u5ea6\u5b78\u7fd2\u7684\u9032\u6b65\u5728\u91ab\u5b78\u5f71\u50cf\u5206\u6790\u4e2d\u5c55\u73fe\u4e86\u975e\u51e1\u7684\u6f5b\u529b\u3002\u65b9\u6cd5\u5728\u9019\u500b\u7814\u7a76\u4e2d\uff0c\u6211\u5011\u63d0\u51fa\u300cViTranZheimer\u300d\uff0c\u4e00\u7a2e AD \u8a3a\u65b7\u65b9\u6cd5\uff0c\u5b83\u5229\u7528\u5f71\u7247\u8996\u89ba\u8f49\u63db\u5668\u4f86\u5206\u6790 3D \u5927\u8166 MRI \u8cc7\u6599\u3002\u900f\u904e\u5c07 3D MRI \u9ad4\u7a4d\u8996\u70ba\u5f71\u7247\uff0c\u6211\u5011\u5229\u7528\u5207\u7247\u4e4b\u9593\u7684\u6642\u9593\u4f9d\u8cf4\u6027\u4f86\u6355\u6349\u8907\u96dc\u7684\u7d50\u69cb\u95dc\u4fc2\u3002\u5f71\u7247\u8996\u89ba\u8f49\u63db\u5668\u7684\u81ea\u6ce8\u610f\u529b\u6a5f\u5236\u4f7f\u6a21\u578b\u80fd\u5920\u5b78\u7fd2\u9577\u7a0b\u4f9d\u8cf4\u6027\uff0c\u4e26\u8b58\u5225\u53ef\u80fd\u8868\u793a AD \u9032\u5c55\u7684\u7d30\u5fae\u6a21\u5f0f\u3002\u6211\u5011\u63d0\u51fa\u7684\u6df1\u5ea6\u5b78\u7fd2\u67b6\u69cb\u65e8\u5728\u63d0\u9ad8 AD \u8a3a\u65b7\u7684\u6e96\u78ba\u6027\u548c\u654f\u611f\u6027\uff0c\u70ba\u81e8\u5e8a\u91ab\u751f\u63d0\u4f9b\u65e9\u671f\u6aa2\u6e2c\u548c\u5e72\u9810\u7684\u5de5\u5177\u3002\u6211\u5011\u4f7f\u7528 ADNI \u8cc7\u6599\u96c6\u9a57\u8b49\u5f71\u7247\u8996\u89ba\u8f49\u63db\u5668\u7684\u6548\u80fd\uff0c\u4e26\u8207\u5176\u4ed6\u76f8\u95dc\u6a21\u578b\u9032\u884c\u6bd4\u8f03\u5206\u6790\u3002\u7d50\u679c\u6240\u63d0\u51fa\u7684 ViTranZheimer \u6a21\u578b\u8207\u5169\u500b\u6df7\u5408\u6a21\u578b CNN-BiLSTM \u548c ViT-BiLSTM \u9032\u884c\u6bd4\u8f03\u3002CNN-BiLSTM \u662f\u5377\u7a4d\u795e\u7d93\u7db2\u8def (CNN) \u548c\u96d9\u5411\u9577\u77ed\u671f\u8a18\u61b6\u7db2\u8def (BiLSTM) \u7684\u7d44\u5408\uff0c\u800c ViT-BiLSTM \u662f\u8996\u89ba\u8f49\u63db\u5668 (ViT) \u8207 BiLSTM \u7684\u7d44\u5408\u3002\u5728 ViTranZheimer\u3001CNN-BiLSTM \u548c ViT-BiLSTM \u6a21\u578b\u4e2d\u9054\u5230\u7684\u6e96\u78ba\u5ea6\u5206\u5225\u70ba 98.6%\u300196.479% \u548c 97.465%\u3002ViTranZheimer \u4ee5 98.6% \u7684\u6e96\u78ba\u5ea6\u8868\u73fe\u6700\u4f73\uff0c\u5728\u9019\u500b\u8a55\u4f30\u6307\u6a19\u4e2d\u512a\u65bc\u5176\u4ed6\u6a21\u578b\uff0c\u986f\u793a\u51fa\u5176\u5728\u9019\u500b\u7279\u5b9a\u8a55\u4f30\u6307\u6a19\u4e2d\u7684\u5353\u8d8a\u6548\u80fd\u3002\u7d50\u8ad6\u9019\u9805\u7814\u7a76\u4fc3\u9032\u4e86\u5728\u795e\u7d93\u5f71\u50cf\u548c\u963f\u8332\u6d77\u9ed8\u75c7\u7814\u7a76\u4e2d\u61c9\u7528\u6df1\u5ea6\u5b78\u7fd2\u6280\u8853\u7684\u7406\u89e3\uff0c\u70ba\u66f4\u65e9\u3001\u66f4\u4f4e\u4fb5\u5165\u6027\u7684\u81e8\u5e8a\u8a3a\u65b7\u92ea\u8def\u3002", "author": "Taymaz Akan et.al.", "authors": "Taymaz Akan, Sait Alp, Md. Shenuarin Bhuiyan, Elizabeth A. Disbrow, Steven A. Conrad, John A. Vanchiere, Christopher G. Kevil, Mohammad A. N. Bhuiyan", "id": "2501.15733v1", "paper_url": "http://arxiv.org/abs/2501.15733v1", "repo": "null"}}